Cargando…
Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.
Autores principales: | Pavlou, Panagiotis, Koutroukas, Vaios, Lissett, Catherine, Smith, Jamie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517595/ https://www.ncbi.nlm.nih.gov/pubmed/34691455 http://dx.doi.org/10.1002/ccr3.4830 |
Ejemplares similares
-
Hypertonic saline versus fluid restriction: The pitfalls in managing acute hyponatremia in a patient with long‐standing spinal cord injury
por: Koutroukas, Vaios, et al.
Publicado: (2022) -
Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus
por: Rosenson, Robert S., et al.
Publicado: (2014) -
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
por: Sekhri, Kavita, et al.
Publicado: (2011) -
Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
por: Nwose, Oliseyenum M., et al.
Publicado: (2013) -
Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action
por: Zema, Michael James
Publicado: (2012)